Advanced search
Publication Cover
International Reviews of Immunology Volume 41, 2022 - Issue 5
Submit an article Journal homepage
330
Views
1
CrossRef citations to date
0
Altmetric
Reviews

T cell transgressions: Tales of T cell form and function in diverse disease states

Kevin M. HarrisDepartment of Psychology and Neuroscience, Center for Neuroscience, University of Colorado, Boulder, Colorado, USAView further author information
,
Madison A. ClementsDepartment of Psychology and Neuroscience, Center for Neuroscience, University of Colorado, Boulder, Colorado, USAView further author information
,
Andrew J. KwilaszDepartment of Psychology and Neuroscience, Center for Neuroscience, University of Colorado, Boulder, Colorado, USAView further author information
&
Linda R. WatkinsDepartment of Psychology and Neuroscience, Center for Neuroscience, University of Colorado, Boulder, Colorado, USACorrespondence[email protected]
View further author information
Pages 475-516 | Received 10 Feb 2021, Accepted 20 Apr 2021, Published online: 21 Jun 2021

References

  • Gameiro J, Nagib P, Verinaud L. The thymus microenvironment in regulating thymocyte differentiation. Cell Adh Migr. 2010;4(3):382–390. doi:10.4161/cam.4.3.11789.
  • Carmona LM, Fugmann SD, Schatz DG. Collaboration of RAG2 with RAG1-like proteins during the evolution of V(D)J recombination. Genes Dev. 2016;30(8):909–917. doi:10.1101/gad.278432.116.
  • Klein L, Kyewski B, Allen PM, Hogquist KA. Positive and negative selection of the T cell repertoire: what thymocytes see (and don’t see). Nat Rev Immunol. 2014;14(6):377–391. doi:10.1038/nri3667.
  • Kono M, Maeda K, Stocton-Gavanescu I, et al. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation. JCI Insight. 2019;4(12). doi:10.1172/jci.insight.127395.
  • Kondo K, Ohigashi I, Takahama Y. Thymus machinery for T-cell selection. Int Immunol. 2019;31(3):119–125. doi:10.1093/intimm/dxy081.
  • Ueno T, Saito F, Gray DHD, et al. CCR7 signals are essential for cortex-medulla migration of developing thymocytes. J Exp Med. 2004;200(4):493–505. doi:10.1084/jem.20040643.
  • Esensten JH, Helou YA, Chopra G, Weiss A, Bluestone JA. CD28 Costimulation: from mechanism to therapy. Immunity. 2016;44(5):973–988. doi:10.1016/j.immuni.2016.04.020.
  • Courtney AH, Lo W-L, Weiss A. TCR signaling: mechanisms of initiation and propagation. Trends Biochem Sci. 2018;43(2):108–123. doi:10.1016/j.tibs.2017.11.008.
  • Hatada MH, Lu X, Laird ER, et al. Molecular basis for interaction of the protein tyrosine kinase ZAP-70 with the T-cell receptor. Nature. 1995;377(6544):32–38. doi:10.1038/377032a0.
  • Deindl S, Kadlecek TA, Brdicka T, et al. Structural basis for the inhibition of tyrosine kinase activity of ZAP-70. Cell. 2007;129(4):735–746. doi:10.1016/j.cell.2007.03.039.
  • Yan Q, Barros T, Visperas PR, et al. Structural basis for activation of ZAP-70 by phosphorylation of the SH2-kinase linker. Mol Cell Biol. 2013;33(11):2188–2201. doi:10.1128/MCB.01637-12.
  • Thill PA, Weiss A, Chakraborty AK. Phosphorylation of a tyrosine residue on Zap70 by Lck and its subsequent binding via an SH2 domain may be a key gatekeeper of T cell receptor signaling in vivo. Mol Cell Biol. 2016;36(18):2396–2402. doi:10.1128/MCB.00165-16.
  • Balagopalan L, Coussens NP, Sherman E, Samelson LE, Sommers CL. The LAT story: a tale of cooperativity, coordination, and choreography. Cold Spring Harb Perspect Biol. 2010;2(8):a005512. doi:10.1101/cshperspect.a005512.
  • Liu SK, Fang N, Koretzky GA, McGlade CJ. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr Biol. 1999;9(2):67–75. doi:10.1016/S0960-9822(99)80017-7.
  • Zhang W, Trible RP, Zhu M, et al. Association of Grb2, Gads, and phospholipase C-gamma 1 with phosphorylated LAT tyrosine residues. Effect of LAT tyrosine mutations on T cell angigen receptor-mediated signaling. J Biol Chem. 2000;275(30):23355–23361. doi:10.1074/jbc.M000404200.]
  • Castro CD, Boughter CT, Broughton AE, Ramesh A, Adams EJ. Diversity in recognition and function of human γδ T cells. Immunol Rev. 2020;298(1):134–152. doi:10.1111/imr.12930.
  • Huang W, Na L, Fidel PL, Schwarzenberger P. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis. 2004;190(3):624–631. doi:10.1086/422329.
  • Weaver CT, Harrington LE, Mangan PR, Gavrieli M, Murphy KM. Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity. 2006;24(6):677–688. doi:10.1016/j.immuni.2006.06.002.
  • Dominguez-Villar M, Hafler DA. Regulatory T cells in autoimmune diseases. Nat Immunol. 2018;19(7):665–673. doi:10.1038/s41590-018-0120-4.
  • Al K, Gerlach S. C. T cell fate mapping and lineage tracing technologies probing clonal aspects underlying the generation of CD8 T cell subsets. Scand. J. Immunol. 2020;92:e12983.
  • Raphael I, Joern RR, Forsthuber TG. Memory CD4+ T cells in immunity and autoimmune diseases. Cells. 2020;9(3):531. doi:10.3390/cells9030531.
  • Taniuchi I. CD4 helper and CD8 cytotoxic T cell differentiation. Annu Rev Immunol. 2018;36:579–601. doi:10.1146/annurev-immunol-042617-053411.
  • Hsieh C, Macatonia S, Tripp C, et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science. 1993;260(5107):547–549. doi:10.1126/science.8097338.
  • Amsen D, Spilianakis CG, Flavell RA. How are T(H)1 and T(H)2 effector cells made?Curr Opin Immunol. 2009;21(2):153–160. doi:10.1016/j.coi.2009.03.010.
  • Djuretic IM, Levanon D, Negreanu V, et al. Transcription factors T-bet and Runx3 cooperate to activate Ifng and silence Il4 in T helper type 1 cells. Nat Immunol. 2007;8(2):145–153. doi:10.1038/ni1424.
  • Usui T, Preiss JC, Kanno Y, et al. T-bet regulates Th1 responses through essential effects on GATA-3 function rather than on IFNG gene acetylation and transcription. J Exp Med. 2006;203(3):755–766. doi:10.1084/jem.20052165.
  • Luckheeram RV, Zhou R, Verma AD, Xia B. CD4+T cells: differentiation and functions. Clin Dev Immunol. 2012;2012:1–12. doi:10.1155/2012/925135.
  • Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557–1569. doi:10.1182/blood-2008-05-078154.
  • Pennock ND, White JT, Cross EW, et al. T cell responses: naive to memory and everything in between. Adv Physiol Educ. 2013;37(4):273–283. doi:10.1152/advan.00066.2013.
  • Chiang EY, Kolumam GA, Yu X, et al. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat Med. 2009;15(7):766–773. doi:10.1038/nm.1984.
  • Kim HP, Imbert J, Leonard WJ. Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. Cytokine Growth Factor Rev. 2006;17(5):349–366. doi:10.1016/j.cytogfr.2006.07.003.
  • Williams MA, Tyznik AJ, Bevan MJ. Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells. Nature. 2006;441(7095):890–893. doi:10.1038/nature04790.
  • Engel M, Sidwell T, Vasanthakumar A, Grigoriadis G, Banerjee A. Thymic regulatory T cell development: role of signalling pathways and transcription factors. Clin Dev Immunol. 2013;2013:1–8. doi:10.1155/2013/617595.
  • Owen DL, Sjaastad LE, Farrar MA. Regulatory T cell development in the thymus. J Immunol. 2019;203(8):2031–2041. doi:10.4049/jimmunol.1900662.
  • Wuest TY, Willette-Brown J, Durum SK, Hurwitz AA. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J Leukoc Biol. 2008;84(4):973–980. doi:10.1189/jlb.1107778.
  • Zhu J. T helper cell differentiation, heterogeneity, and plasticity. Cold Spring Harb. Perspect. Biol. 2018;10
  • Zhu J, Paul WE. Peripheral CD4+ T-cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010;238(1):247–262. doi:10.1111/j.1600-065X.2010.00951.x.
  • van Hamburg JP, de Bruijn MJW, de Almeida CR, et al. Enforced expression of GATA3 allows differentiation of IL-17-producing cells, but constrains Th17-mediated pathology. Eur J Immunol. 2008;38(9):2573–2586. doi:10.1002/eji.200737840.
  • Sokol CL, Chu N-Q, Yu S, et al. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol. 2009;10(7):713–720. doi:10.1038/ni.1738.
  • Taylor-Robinson AW, Phillips RS. Functional characterization of protective CD4+ T-cell clones reactive to the murine malaria parasite Plasmodium chabaudi. Immunology. 1992;77(1):99–105.
  • Kopf M, Le Gros G, Bachmann M, et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993;362(6417):245–248. doi:10.1038/362245a0.
  • Steinke JW, Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res. 2001;2(2):66–70. [Database] doi:10.1186/rr40.
  • Doucet C, Brouty-Boyé D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol. 1998;10(10):1421–1433. doi:10.1093/intimm/10.10.1421.
  • Le Gros G, Ben-Sasson SZ, Seder R, Finkelman FD, Paul WE. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. J Exp Med. 1990;172(3):921–929. doi:10.1084/jem.172.3.921.
  • Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol Baltim Md 1950. 1990;145:3796–3806.
  • Coffman R, Seymour B, Hudak S, Jackson J, Rennick D. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 1989;245(4915):308–310. doi:10.1126/science.2787531.
  • Martinez-Moczygemba M, Huston DP. Biology of common beta receptor-signaling cytokines: IL-3, IL-5, and GM-CSF. J Allergy Clin Immunol. 2003;112(653–665):666. quiz
  • Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 1991;78(10):2542–2547. doi:10.1182/blood.V78.10.2542.2542.
  • Longphre M, Li D, Gallup M, et al. Allergen-induced IL-9 directly stimulates mucin transcription in respiratory epithelial cells. J Clin Invest. 1999;104(10):1375–1382.,. doi:10.1172/JCI6097.
  • Couper KN, Blount DG, Riley EM. IL-10: the master regulator of immunity to infection. J Immunol. 2008;180(9):5771–5777. doi:10.4049/jimmunol.180.9.5771.
  • Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21(1):425–456. doi:10.1146/annurev.immunol.21.120601.141142.
  • Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203(4):1105–1116. doi:10.1084/jem.20051615.
  • Kleinschek MA, Owyang AM, Joyce-Shaikh B, et al. IL-25 regulates Th17 function in autoimmune inflammation. J Exp Med. 2007;204(1):161–170. doi:10.1084/jem.20061738.
  • Zaiss DM, Yang L, Shah PR, et al. Amphiregulin, a TH2 cytokine enhancing resistance to nematodes. Science. 2006;314(5806):1746. doi:10.1126/science.1133715.
  • Zhang S. The role of transforming growth factor β in T helper 17 differentiation. Immunology. 2018;155(1):24–35. doi:10.1111/imm.12938.
  • Durant L, Watford WT, Ramos HL, et al. Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity. 2010;32(5):605–615. doi:10.1016/j.immuni.2010.05.003.
  • Yang XO, Pappu BP, Nurieva R, et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma. Immunity. 2008;28(1):29–39. doi:10.1016/j.immuni.2007.11.016.
  • Zhang S, Takaku M, Zou L, et al. Reversing SKI-SMAD4-mediated suppression is essential for TH17 cell differentiation. Nature. 2017;551(7678):105–109. doi:10.1038/nature24283.
  • Zhang J, Zhang Y, Wang Q, et al. Interleukin-35 in immune-related diseases: protection or destruction. Immunology. 2019;157(1):13–20. doi:10.1111/imm.13044.
  • Annunziato F, Cosmi L, Santarlasci V, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204(8):1849–1861. doi:10.1084/jem.20070663.
  • Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):1121–1133. doi:10.1016/j.cell.2006.07.035.
  • Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol. 2009;9(8):556–567. doi:10.1038/nri2586.
  • Hymowitz SG, Filvaroff EH, Yin JP, et al. IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding. Embo J. 2001;20(19):5332–5341. doi:10.1093/emboj/20.19.5332.
  • Yao Z, Fanslow WC, Seldin MF, et al. Herpesvirus saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity. 1995;3(6):811–821. doi:10.1016/1074-7613(95)90070-5.
  • Korn T, Reddy J, Gao W, et al. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med. 2007;13(4):423–431. doi:10.1038/nm1564.
  • Nurieva R, Yang XO, Martinez G, et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature. 2007;448(7152):480–483. doi:10.1038/nature05969.
  • Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol. 2005;5(9):688–698. doi:10.1038/nri1688.
  • Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature. 2006;441(7090):235–238. doi:10.1038/nature04753.
  • McGeachy MJ, Bak-Jensen KS, Chen Y, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol. 2007;8(12):1390–1397. doi:10.1038/ni1539.
  • Wang C, Yosef N, Gaublomme J, et al. CD5L/AIM regulates lipid biosynthesis and restrains Th17 cell pathogenicity. Cell. 2015;163(6):1413–1427. doi:10.1016/j.cell.2015.10.068.
  • Chang K-K, Liu L-B, Jin L-P, et al. IL-27 triggers IL-10 production in Th17 cells via a c-Maf/RORγt/Blimp-1 signal to promote the progression of endometriosis. Cell Death Dis. 2017;8(3):e2666–e2666. doi:10.1038/cddis.2017.95.
  • Xu J, Yang Y, Qiu G, et al. c-Maf regulates IL-10 expression during Th17 polarization. J Immunol. 2009;182(10):6226–6236. doi:10.4049/jimmunol.0900123.
  • Ghoreschi K, Laurence A, Yang X-P, et al. Generation of pathogenic TH17 cells in the absence of TGF-β signalling. Nature. 2010;467(7318):967–971. doi:10.1038/nature09447.
  • Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med. 2005;201(2):233–240. doi:10.1084/jem.20041257.
  • Lee Y, Awasthi A, Yosef N, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol. 2012;13(10):991–999. doi:10.1038/ni.2416.
  • Chung Y, Chang SH, Martinez GJ, et al. Critical regulation of early Th17 Cell differentiation by interleukin-1 signaling. Immunity. 2009;30(4):576–587. doi:10.1016/j.Immuni.2009.02.007.
  • Wu B, Zhang S, Guo Z, et al. The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 2021;54(2):308–323.e6. doi:10.1016/j.immuni.2020.12.010.
  • Ahern PP, Schiering C, Buonocore S, et al. Interleukin-23 drives intestinal inflammation through direct activity on T cells. Immunity. 2010;33(2):279–288. doi:10.1016/j.immuni.2010.08.010.
  • Meyer Zu Horste G, Wu C, Wang C, et al. RBPJ controls development of pathogenic Th17 cells by regulating IL-23 receptor expression. Cell Rep. 2016;16(2):392–404. doi:10.1016/j.celrep.2016.05.088.
  • Codarri L, Gyülvészi G, Tosevski V, et al. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat Immunol. 2011;12(6):560–567. doi:10.1038/ni.2027.
  • Jain R, Chen Y, Kanno Y, et al. Interleukin-23-induced transcription factor Blimp-1 promotes pathogenicity of T helper 17 cells. Immunity. 2016;44(1):131–142. doi:10.1016/j.immuni.2015.11.009.
  • Sonderegger I, Iezzi G, Maier R, et al. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J Exp Med. 2008;205(10):2281–2294. doi:10.1084/jem.20071119.
  • Liang SC, Tan X-Y, Luxenberg DP, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med. 2006;203(10):2271–2279. doi:10.1084/jem.20061308.
  • Zheng Y, Danilenko DM, Valdez P, et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature. 2007;445(7128):648–651. doi:10.1038/nature05505.
  • Sakaguchi S. Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol. 2004;22:531–562. doi:10.1146/annurev.immunol.21.120601.141122.
  • Martinez GJ, Zhang Z, Chung Y, et al. Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J Biol Chem. 2009;284(51):35283–35286. doi:10.1074/jbc.C109.078238.
  • Yang CY, Best JA, Knell J, et al. The transcriptional regulators Id2 and Id3 control the formation of distinct memory CD8+ T cell subsets. Nat Immunol. 2011;12(12):1221–1229. doi:10.1038/ni.2158.
  • Zheng SG, Wang J, Horwitz DA. Cutting edge: Foxp3 + CD4 + CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol. 2008;180(11):7112–7116. 1950 doi:10.4049/jimmunol.180.11.7112.
  • Wing JB, Tay C, Sakaguchi S. Control of regulatory T cells by Co-signal molecules. Adv Exp Med Biol. 2019;1189:179–210. doi:10.1007/978-981-32-9717-3_7.
  • Owen DL, Mahmud SA, Sjaastad LE, et al. Thymic regulatory T cells arise via two distinct developmental programs. Nat Immunol. 2019;20(2):195–205. doi:10.1038/s41590-018-0289-6.
  • Santamaria JC, Borelli A, Irla M. Regulatory T cell heterogeneity in the thymus: impact on their functional activities. Front Immunol. 2021;12:643153.
  • Peligero-Cruz C, Givony T, Sebé-Pedrós A, et al. IL18 signaling promotes homing of mature Tregs into the thymus. eLife. 2020;9. doi:10.7554/eLife.58213.
  • Nikolouli E, Elfaki Y, Herppich S, et al. Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions. Cell Mol Immunol. 2021;18(1):182–193. doi:10.1038/s41423-019-0352-8.
  • Brunkow ME, Jeffery EW, Hjerrild KA, et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet. 2001;27(1):68–73. doi:10.1038/83784.
  • Kuniyasu Y, Takahashi T, Itoh M, et al. Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol. 2000;12(8):1145–1155. doi:10.1093/intimm/12.8.1145.
  • Chen WJun, Jin W, Hardegen N, et al. Conversion of peripheral CD4 + CD25− Naive T cells to CD4 + CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3. J Exp Med. 2003;198(12):1875–1886. doi:10.1084/jem.20030152.
  • Li Y, Chu N, Hu A, et al. Increased IL-23p19 expression in multiple sclerosis lesions and its induction in microglia. Brain. 2007;130(Pt 2):490–501. doi:10.1093/brain/awl273.
  • Jutel M, Akdis CA. T-cell regulatory mechanisms in specific immunotherapy. In Blaser, K, ed. Chemical Immunology and Allergy. KARGER, 2008;94:158–177.
  • Ouyang W, Rutz S, Crellin NK, Valdez PA, Hymowitz SG. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu Rev Immunol. 2011;29(1):71–109. doi:10.1146/annurev-immunol-031210-101312.
  • Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med. 1999;190(7):995–1004. doi:10.1084/jem.190.7.995.
  • Collison LW, Pillai MR, Chaturvedi V, Vignali DAA. Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J Immunol. 2009;182(10):6121–6128. doi:10.4049/jimmunol.0803646.
  • Kavazović I, Polić B, Wensveen FM. Cheating the hunger games; mechanisms controlling clonal diversity of CD8 effector and memory populations. Front Immunol. 2018;9:2831. doi:10.3389/fimmu.2018.02831.
  • Mescher MF, Curtsinger JM, Agarwal P, et al. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev. 2006;211(1):81–92. doi:10.1111/j.0105-2896.2006.00382.x.
  • St Paul M, Ohashi PS. The roles of CD8+ T cell subsets in antitumor immunity. Trends Cell Biol. 2020;30(9):695–704. doi:10.1016/j.tcb.2020.06.003.
  • Chang JT, Wherry EJ, Goldrath AW. Molecular regulation of effector and memory T cell differentiation. Nat Immunol. 2014;15(12):1104–1115. doi:10.1038/ni.3031.
  • Daniels MA, Teixeiro E. TCR signaling in T cell memory. Front Immunol. 2015;6 doi:10.3389/fimmu.2015.00617.
  • Knudson KM, Goplen NP, Cunningham CA, Daniels MA, Teixeiro E. Low-affinity T cells are programmed to maintain normal primary responses but are impaired in their recall to low-affinity ligands. Cell Rep. 2013;4(3):554–565. doi:10.1016/j.celrep.2013.07.008.
  • Chen Y, Zander R, Khatun A, Schauder DM, Cui W. Transcriptional and epigenetic regulation of effector and memory CD8 T cell differentiation. Front Immunol. 2018;9:2826. doi:10.3389/fimmu.2018.02826.
  • Thaventhiran JED, Fearon DT, Gattinoni L. Transcriptional regulation of effector and memory CD8+ T cell fates. Curr Opin Immunol. 2013;25(3):321–328. doi:10.1016/j.coi.2013.05.010.
  • Ji Y, Pos Z, Rao M, et al. Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cells. Nat Immunol. 2011;12(12):1230–1237. doi:10.1038/ni.2153.
  • Samji T, Khanna KM. Understanding memory CD8+ T cells. Immunol Lett. 2017;185:32–39. doi:10.1016/j.imlet.2017.02.012.
  • Valbon SF, Condotta SA, Richer MJ. Regulation of effector and memory CD8(+) T cell function by inflammatory cytokines. Cytokine. 2016;82:16–23. doi:10.1016/j.cyto.2015.11.013.
  • Zhang N, Bevan MJ. CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011;35(2):161–168. doi:10.1016/j.immuni.2011.07.010.
  • Andersen MH, Schrama D, Thor Straten P, Becker JC. Cytotoxic T cells. J Invest Dermatol. 2006;126(1):32–41. doi:10.1038/sj.jid.5700001.
  • Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science. 2002;295(5553):338–342. doi:10.1126/science.1065543.
  • Tummers B, Green DR. Caspase-8: regulating life and death. Immunol Rev. 2017;277(1):76–89. doi:10.1111/imr.12541.
  • Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163–189. doi:10.1189/jlb.0603252.
  • Nagata S. Fas-mediated apoptosis. Adv Exp Med Biol. 1996;406:119–124. doi:10.1007/978-1-4899-0274-0_12.
  • Voskoboinik I, Whisstock JC, Trapani JA. Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol. 2015;15(6):388–400. doi:10.1038/nri3839.
  • Su MW-C, Pyarajan S, Chang J-H, et al. Fratricide of CD8+ cytotoxic T lymphocytes is dependent on cellular activation and perforin-mediated killing. Eur J Immunol. 2004;34(9):2459–2470. doi:10.1002/eji.200425096.
  • Joshi NS, Cui W, Chandele A, et al. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27(2):281–295. doi:10.1016/j.immuni.2007.07.010.
  • Doherty PC, Hou S, Tripp RA. CD8+ T-cell memory to viruses. Curr Opin Immunol. 1994;6(4):545–552. doi:10.1016/0952-7915(94)90139-2.
  • Hammarlund E, Lewis MW, Hansen SG, et al. Duration of antiviral immunity after smallpox vaccination. Nat Med. 2003;9(9):1131–1137. doi:10.1038/nm917.
  • Nolz JC. Molecular mechanisms of CD8(+) T cell trafficking and localization. Cell Mol Life Sci. 2015;72(13):2461–2473. doi:10.1007/s00018-015-1835-0.
  • Gebhardt T, Mackay LK. Local immunity by tissue-resident CD8+ memory T cells. Front. Immunol. 2012;3
  • Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol. 2010;10(7):479–489. doi:10.1038/nri2800.
  • He D, Wu L, Kim HK, et al. CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses. J Immunol. 2006;177(10):6852–6858. doi:10.4049/jimmunol.177.10.6852.
  • Villanova F, Flutter B, Tosi I, et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol. 2014;134(4):984–991. doi:10.1038/jid.2013.477.
  • Ramirez-Carrozzi V, Sambandam A, Luis E, et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol. 2011;12(12):1159–1166. doi:10.1038/ni.2156.
  • Iwakura Y, Ishigame H, Saijo S, Nakae S. Functional Specialization of Interleukin-17 Family Members. Immunity. 2011;34(2):149–162. doi:10.1016/j.immuni.2011.02.012.
  • Li H, Chen J, Huang A, et al. Cloning and characterization of IL-17B and IL-17C, two new members of the IL-17 cytokine family. Proc Natl Acad Sci USA. 2000;97(2):773–778. doi:10.1073/pnas.97.2.773.
  • Starnes T, Broxmeyer HE, Robertson MJ, Hromas R. Cutting edge: IL-17D, a novel member of the IL-17 family, stimulates cytokine production and inhibits hemopoiesis. J. Immunol. Baltim. Md 1950. 2002;169:642–646.
  • Muñoz-Ruiz M, Sumaria N, Pennington DJ, Silva-Santos B. Thymic determinants of γδ T cell differentiation. Trends Immunol. 2017;38(5):336–344. doi:10.1016/j.it.2017.01.007.
  • Liang SC, Long AJ, Bennett F, et al. An IL-17F/A heterodimer protein is produced by mouse Th17 cells and induces airway neutrophil recruitment. J Immunol. 2007;179(11):7791–7799. doi:10.4049/jimmunol.179.11.7791.
  • Wright JF, Bennett F, Li B, et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol. 2008;181(4):2799–2805. 1950 doi:10.4049/jimmunol.181.4.2799.
  • Rickel EA, Siegel LA, Yoon B-RP, et al. Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities. J Immunol. 2008;181(6):4299–4310. doi:10.4049/jimmunol.181.6.4299.
  • Shi Y, Ullrich SJ, Zhang J, et al. A novel cytokine receptor-ligand pair. Identification, molecular characterization, and in vivo immunomodulatory activity. J Biol Chem. 2000;275(25):19167–19176. doi:10.1074/jbc.M910228199.
  • Novatchkova M, Leibbrandt A, Werzowa J, Neubüser A, Eisenhaber F. The STIR-domain superfamily in signal transduction, development and immunity. Trends Biochem Sci. 2003;28(5):226–229. doi:10.1016/S0968-0004(03)00067-7.
  • Qian Y, Liu C, Hartupee J, et al. The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007;8(3):247–256. doi:10.1038/ni1439.
  • Schwandner R, Yamaguchi K, Cao Z. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J Exp Med. 2000;191(7):1233–1240. doi:10.1084/jem.191.7.1233.
  • Liu C, Qian W, Qian Y, et al. Act1, a U-box E3 ubiquitin ligase for IL-17 signaling. Sci Signal. 2009;2(92):ra63–ra63. doi:10.1126/scisignal.2000382.
  • Napetschnig J, Wu H. Molecular basis of NF-κB signaling. Annu Rev Biophys. 2013;42(1):443–468. doi:10.1146/annurev-biophys-083012-130338.
  • Hata K, Andoh A, Shimada M, et al. IL-17 stimulates inflammatory responses via NF-κB and MAP kinase pathways in human colonic myofibroblasts. Am J Physiol Gastrointest Liver Physiol. 2002;282(6):G1035–G1044. doi:10.1152/ajpgi.00494.2001.
  • Ruddy MJ, Wong GC, Liu XK, et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem. 2004;279(4):2559–2567. doi:10.1074/jbc.M308809200.
  • Bulek K, Liu C, Swaidani S, et al. The inducible kinase IKKi is required for IL-17-dependent signaling associated with neutrophilia and pulmonary inflammation. Nat Immunol. 2011;12(9):844–852. doi:10.1038/ni.2080.
  • Qu F, Gao H, Zhu S, et al. TRAF6-dependent Act1 phosphorylation by the IκB kinase-related kinases suppresses interleukin-17-induced NF-κB activation. Mol Cell Biol. 2012;32(19):3925–3937. doi:10.1128/MCB.00268-12.
  • Herjan T, Yao P, Qian W, et al. HuR is required for IL-17-induced Act1-mediated CXCL1 and CXCL5 mRNA stabilization. J Immunol. 2013;191(2):640–649. doi:10.4049/jimmunol.1203315.
  • Sun D, Novotny M, Bulek K, et al. Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF). Nat Immunol. 2011;12(9):853–860. doi:10.1038/ni.2081.
  • Claudio E, Sønder SU, Saret S, et al. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J Immunol. 2009;182(3):1617–1630. doi:10.4049/jimmunol.182.3.1617.
  • Maezawa Y, Nakajima H, Suzuki K, et al. Involvement of TNF receptor-associated factor 6 in IL-25 receptor signaling. J Immunol. 2006;176(2):1013–1018. 1950 doi:10.4049/jimmunol.176.2.1013.
  • Swaidani S, Bulek K, Kang Z, et al. The critical role of epithelial-derived Act1 in IL-17- and IL-25-mediated pulmonary inflammation. J Immunol. 2009;182(3):1631–1640. doi:10.4049/jimmunol.182.3.1631.
  • Zepp JA, Wu L, Qian W, et al. TRAF4-SMURF2-mediated DAZAP2 degradation is critical for IL-25 signaling and allergic airway inflammation. J Immunol. 2015;194(6):2826–2837. doi:10.4049/jimmunol.1402647.
  • Wu L, Zepp JA, Qian W, et al. A novel IL-25 signaling pathway through STAT5. J Immunol. 2015;194(9):4528–4534. doi:10.4049/jimmunol.1402760.
  • Shen F, Ruddy MJ, Plamondon P, Gaffen SL. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol. 2005;77(3):388–399. doi:10.1189/jlb.0904490.
  • Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol. 2007;8(6):639–646. doi:10.1038/ni1467.
  • Reynolds JM, Lee Y-H, Shi Y, et al. Interleukin-17B antagonizes interleukin-25-mediated mucosal inflammation. Immunity. 2015;42(4):692–703. doi:10.1016/j.immuni.2015.03.008.
  • Chang SH, Reynolds JM, Pappu BP, et al. Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E. Immunity. 2011;35(4):611–621. doi:10.1016/j.immuni.2011.09.010.]
  • Johansen C, Usher PA, Kjellerup RB, et al. Characterization of the interleukin-17 isoforms and receptors in lesional psoriatic skin. Br J Dermatol. 2009;160(2):319–324. doi:10.1111/j.1365-2133.2008.08902.x.
  • Nograles KE, Zaba LC, Guttman-Yassky E, et al. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways. Br J Dermatol. 2008;159(5):1092–1102. doi:10.1111/j.1365-2133.2008.08769.x.
  • O’Sullivan T, Saddawi-Konefka R, Gross E, et al. Interleukin-17D mediates tumor rejection through recruitment of natural killer cells. Cell Rep. 2014;7(4):989–998. doi:10.1016/j.celrep.2014.03.073.
  • Corrigan CJ, Wang W, Meng Q, et al. Allergen-induced expression of IL-25 and IL-25 receptor in atopic asthmatic airways and late-phase cutaneous responses. J. Allergy Clin. Immunol. 2011;128(1):116–124. doi:10.1016/j.jaci.2011.03.043.
  • Fort MM, Cheung J, Yen D, et al. IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo. Immunity. 2001;15(6):985–995. doi:10.1016/S1074-7613(01)00243-6.
  • Pan G, French D, Mao W, et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice. J Immunol. 2001;167(11):6559–6567. doi:10.4049/jimmunol.167.11.6559.
  • Wang Y-H, Angkasekwinai P, Lu N, et al. IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells. J Exp Med. 2007;204(8):1837–1847. doi:10.1084/jem.20070406.
  • Cheng D, Xue Z, Yi L, et al. Epithelial interleukin-25 is a key mediator in Th2-high, corticosteroid-responsive asthma. Am J Respir Crit Care Med. 2014;190(6):639–648. doi:10.1164/rccm.201403-0505OC.
  • D’Andrea A, Rengaraju M, Valiante NM, et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med. 1992;176:1387–1398.
  • Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol Baltim Md 1950. 1995;154:5071–5079.
  • Schultze JL, Michalak S, Lowne J, et al. Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cell signals CD40 ligand, interferon gamma, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med. 1999;189(1):1–12. doi:10.1084/jem.189.1.1.
  • Jones LL, Vignali DAA. Molecular interactions within the IL-6/IL-12 cytokine/receptor superfamily. Immunol Res. 2011;51(1):5–14. doi:10.1007/s12026-011-8209-y.
  • Teng MWL, Bowman EP, McElwee JJ, et al. IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases. Nat Med. 2015;21(7):719–729. doi:10.1038/nm.3895.
  • Oppmann B, Lesley R, Blom B, et al. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13(5):715–725. doi:10.1016/S1074-7613(00)00070-4.
  • Chua AO, et al. Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130. J Immunol Baltim Md 1950. 1994;153:128–136.
  • Parham C, Chirica M, Timans J, et al. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J Immunol. 2002;168(11):5699–5708. doi:10.4049/jimmunol.168.11.5699.
  • Presky DH, Yang H, Minetti LJ, et al. A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits. Proc Natl Acad Sci USA. 1996;93(24):14002–14007. doi:10.1073/pnas.93.24.14002.
  • Jacobson NG, Szabo SJ, Weber-Nordt RM, et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med. 1995;181(5):1755–1762. doi:10.1084/jem.181.5.1755.
  • Thierfelder WE, van Deursen JM, Yamamoto K, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature. 1996;382(6587):171–174. doi:10.1038/382171a0.
  • Bacon CM, McVicar DW, Ortaldo JR, et al. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med. 1995;181(1):399–404. doi:10.1084/jem.181.1.399.
  • Bacon CM, Petricoin EF, Ortaldo JR, et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA. 1995;92(16):7307–7311. doi:10.1073/pnas.92.16.7307.
  • Visconti R, Gadina M, Chiariello M, et al. Importance of the MKK6/p38 pathway for interleukin-12-induced STAT4 serine phosphorylation and transcriptional activity. Blood. 2000;96(5):1844–1852. doi:10.1182/blood.V96.5.1844.h8001844_1844_1852.
  • Yoo JK, Cho JH, Lee SW, Sung YC. IL-12 provides proliferation and survival signals to murine CD4+ T cells through phosphatidylinositol 3-kinase/Akt signaling pathway. J Immunol. 2002;169(7):3637–3643. doi:10.4049/jimmunol.169.7.3637.
  • Ma X, Chow JM, Gri G, et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells. J Exp Med. 1996;183(1):147–157. doi:10.1084/jem.183.1.147.
  • Cho M-L, Kang J-W, Moon Y-M, et al. STAT3 and NF-κB signal pathway is required for IL-23-mediated IL-17 production in Spontaneous arthritis animal model IL-1 receptor antagonist-deficient mice. J Immunol. 2006;176(9):5652–5661. doi:10.4049/jimmunol.176.9.5652.
  • Yang XO, Panopoulos AD, Nurieva R, et al. STAT3 regulates cytokine-mediated generation of inflammatory helper T cells. J Biol Chem. 2007;282(13):9358–9363. doi:10.1074/jbc.C600321200.
  • Cargill M, Schrodi SJ, Chang M, et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet. 2007;80(2):273–290. doi:10.1086/511051.
  • Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 2003;421(6924):744–748. doi:10.1038/nature01355.
  • Zaky DSE, El-Nahrery EMA. Role of interleukin-23 as a biomarker in rheumatoid arthritis patients and its correlation with disease activity. Int. Immunopharmacol. 2016;31:105–108. doi:10.1016/j.intimp.2015.12.011.
  • Paré A, Mailhot B, Lévesque SA, Lacroix S. Involvement of the IL-1 system in experimental autoimmune encephalomyelitis and multiple sclerosis: Breaking the vicious cycle between IL-1β and GM-CSF. Brain Behav Immun. 2017;62:1–8. doi:10.1016/j.bbi.2016.07.146.
  • Hamilton JA, Stanley ER, Burgess AW, Shadduck RK. Stimulation of macrophage plasminogen activator activity by colony-stimulating factors. J Cell Physiol. 1980;103(3):435–445. doi:10.1002/jcp.1041030309.
  • Magri G, Miyajima M, Bascones S, et al. Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol. 2014;15(4):354–364. doi:10.1038/ni.2830.
  • Ponomarev ED, Shriver LP, Maresz K, et al. GM-CSF production by autoreactive T cells is required for the activation of microglial cells and the onset of experimental autoimmune encephalomyelitis. J Immunol. 2007;178(1):39–48. doi:10.4049/jimmunol.178.1.39.
  • Sawada M, Itoh Y, Suzumura A, Marunouchi T. Expression of cytokine receptors in cultured neuronal and glial cells. Neurosci Lett. 1993;160(2):131–134. doi:10.1016/0304-3940(93)90396-3.
  • Shi Y, Liu CH, Roberts AI, et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don’t know. Cell Res. 2006;16(2):126–133. doi:10.1038/sj.cr.7310017.
  • Wheeler MA, Clark IC, Tjon EC, et al. MAFG-driven astrocytes promote CNS inflammation. Nature. 2020;578(7796):593–599. doi:10.1038/s41586-020-1999-0.
  • Burgess AW, Metcalf D. The nature and action of granulocyte-macrophage colony stimulating factors. Blood. 1980;56(6):947–958. doi:10.1182/blood.V56.6.947.bloodjournal566947.
  • Inaba K, Inaba M, Deguchi M, et al. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. Proc Natl Acad Sci USA. 1993;90(7):3038–3042. doi:10.1073/pnas.90.7.3038.
  • Guilliams M, De Kleer I, Henri S, et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J Exp Med. 2013;210(10):1977–1992. doi:10.1084/jem.20131199.
  • Shibata Y, Berclaz P-Y, Chroneos ZC, et al. GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. Immunity. 2001;15(4):557–567. doi:10.1016/S1074-7613(01)00218-7.
  • Rosen LB, Freeman AF, Yang LM, et al. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013;190(8):3959–3966. doi:10.4049/jimmunol.1202526.
  • Dougan M, Dranoff G, Dougan SK. GM-CSF, IL-3, and IL-5 family of cytokines: regulators of inflammation. Immunity. 2019;50(4):796–811. doi:10.1016/j.immuni.2019.03.022.
  • Parajuli B, Sonobe Y, Kawanokuchi J, et al. GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia. J Neuroinflammation. 2012;9:268. doi:10.1186/1742-2094-9-268.
  • Sorgi CA, Rose S, Court N, et al. GM-CSF priming drives bone marrow-derived macrophages to a pro-inflammatory pattern and downmodulates PGE2 in response to TLR2 ligands. PloS One. 2012;7(7):e40523. doi:10.1371/journal.pone.0040523.
  • Uchida K, Beck DC, Yamamoto T, et al. GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis. N Engl J Med. 2007;356(6):567–579. doi:10.1056/NEJMoa062505.
  • Hansen G, Hercus TR, McClure BJ, et al. The structure of the GM-CSF receptor complex reveals a distinct mode of cytokine receptor activation. Cell. 2008;134(3):496–507. doi:10.1016/j.cell.2008.05.053.
  • Brizzi MF, Zini MG, Aronica MG, et al. Convergence of signaling by interleukin-3, granulocyte-macrophage colony-stimulating factor, and mast cell growth factor on JAK2 tyrosine kinase. J Biol Chem. 1994;269(50):31680–31684. doi:10.1016/S0021-9258(18)31749-6.
  • Broughton SE, Hercus TR, Nero TL, et al. Conformational changes in the GM-CSF receptor suggest a molecular mechanism for affinity conversion and receptor signaling. Structure. 2016;24(8):1271–1281. doi:10.1016/j.str.2016.05.017.
  • Guthridge MA, Stomski FC, Thomas D, et al. Mechanism of activation of the GM-CSF, IL-3, and IL-5 family of receptors. Stem Cells. 1998;16(5):301–313. doi:10.1002/stem.160301.
  • Lehtonen A, Matikainen S, Miettinen M, Julkunen I. Granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced STAT5 activation and target-gene expression during human monocyte/macrophage differentiation. J Leukoc Biol. 2002;71(3):511–519.
  • Cook AD, Lee M-C, Saleh R, et al. TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17. JCI Insight. 2018;3(6):e99249. doi:10.1172/jci.insight.99249.
  • Bozinovski S, Jones JE, Vlahos R, Hamilton JA, Anderson GP. Granulocyte/Macrophage-Colony-Stimulating Factor (GM-CSF) regulates lung innate immunity to lipopolysaccharide through Akt/Erk activation of NFκB and AP-1 in Vivo. J Biol Chem. 2002;277(45):42808–42814. doi:10.1074/jbc.M207840200.
  • Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–638. doi:10.1038/nri.2016.90.
  • Mousavi MJ, Mahmoudi M, Ghotloo S. Escape from X chromosome inactivation and female bias of autoimmune diseases. Mol Med. 2020;26(1):127. doi:10.1186/s10020-020-00256-1.
  • Oghumu S, Varikuti S, Stock JC, et al. Cutting edge: CXCR3 escapes X Chromosome Inactivation in T Cells during Infection: Potential Implications for Sex Differences in Immune Responses. J Immunol. 2019;203(4):789–794. doi:10.4049/jimmunol.1800931.
  • Brown MA, Su MA. An Inconvenient Variable: Sex Hormones and Their Impact on T Cell Responses. JI. 2019;202(7):1927–1933. doi:10.4049/jimmunol.1801403.
  • Cleve A, et al. Pharmacology and clinical use of sex steroid hormone receptor modulators. Handb. Exp. Pharmacol. 2012;543–587. doi:10.1007/978-3-642-30726-3_24.
  • Sever R, Glass CK. Signaling by nuclear receptors. Cold Spring Harb Perspect Biol. 2013;5(3):a016709–a016709. doi:10.1101/cshperspect.a016709.
  • Fox HS, Bond BL, Parslow TG. Estrogen regulates the IFN-gamma promoter. J. Immunol. Baltim. Md 1950. 1991;146:4362–4367.
  • Kissick HT, Sanda MG, Dunn LK, et al. Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation. Proc Natl Acad Sci U S A. 2014;111(27):9887–9892. doi:10.1073/pnas.1402468111.
  • Liva SM, Voskuhl RR. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol. 2001;167(4):2060–2067. doi:10.4049/jimmunol.167.4.2060.
  • Kumar N, Shan LX, Hardy MP, Bardin CW, Sundaram K. Mechanism of androgen-induced thymolysis in rats. Endocrinology. 1995;136(11):4887–4893. doi:10.1210/endo.136.11.7588221.
  • Altuwaijri S, Chuang K-H, Lai K-P, et al. Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells. Mol. Endocrinol. Baltim. Md. 2009;23(4):444–453. doi:10.1210/me.2008-0106.
  • Kadel S, Kovats S. Sex Hormones Regulate Innate Immune Cells and Promote Sex Differences in Respiratory Virus Infection. Front Immunol. 2018;9:1653. doi:10.3389/fimmu.2018.01653.
  • Zhang MA, Rego D, Moshkova M, et al. Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way. Proc. Natl. Acad. Sci. U. S. A. 2012;109(24):9505–9510. doi:10.1073/pnas.1118458109.
  • Billi AC, Kahlenberg JM, Gudjonsson JE. Sex bias in autoimmunity. Curr Opin Rheumatol. 2019;31(1):53–61. doi:10.1097/BOR.0000000000000564.
  • Straub RH. The complex role of estrogens in inflammation. Endocr Rev. 2007;28(5):521–574. doi:10.1210/er.2007-0001.
  • Phiel KL, Henderson RA, Adelman SJ, Elloso MM. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol Lett. 2005;97(1):107–113. doi:10.1016/j.imlet.2004.10.007.
  • Kovats S. Estrogen receptors regulate innate immune cells and signaling pathways. Cell Immunol. 2015;294(2):63–69. doi:10.1016/j.cellimm.2015.01.018.
  • Polanczyk MJ, Hopke C, Huan J, Vandenbark AA, Offner H. Enhanced FoxP3 expression and Treg cell function in pregnant and estrogen-treated mice. J Neuroimmunol. 2005;170(1-2):85–92. doi:10.1016/j.jneuroim.2005.08.023.
  • Tai P, Wang J, Jin H, et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol. 2008;214(2):456–464. doi:10.1002/jcp.21221.
  • Bereshchenko O, Bruscoli S, Riccardi C. Glucocorticoids, Sex Hormones, and Immunity. Front Immunol. 2018;9:1332. doi:10.3389/fimmu.2018.01332.
  • Dragin N, Bismuth J, Cizeron-Clairac G, et al. Estrogen-mediated downregulation of AIRE influences sexual dimorphism in autoimmune diseases. J Clin Invest. 2016;126(4):1525–1537. doi:10.1172/JCI81894.
  • Marttila S, Jylhävä J, Nevalainen T, et al. Transcriptional analysis reveals gender-specific changes in the aging of the human immune system. PloS One. 2013;8(6):e66229. doi:10.1371/journal.pone.0066229.
  • Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev. 1996;17(4):369–384. doi:10.1210/edrv-17-4-369.
  • Dosiou C, Hamilton AE, Pang Y, et al. Expression of membrane progesterone receptors on human T lymphocytes and Jurkat cells and activation of G-proteins by progesterone. J Endocrinol. 2008;196(1):67–77. doi:10.1677/JOE-07-0317.
  • Teilmann SC, Clement CA, Thorup J, Byskov AG, Christensen ST. Expression and localization of the progesterone receptor in mouse and human reproductive organs. J Endocrinol. 2006;191(3):525–535. doi:10.1677/joe.1.06565.
  • Hall OJ, Klein SL. Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites. Mucosal Immunol. 2017;10(5):1097–1107. doi:10.1038/mi.2017.35.
  • Tan IJ, Peeva E, Zandman-Goddard G. Hormonal modulation of the immune system - A spotlight on the role of progestogens. Autoimmun Rev. 2015;14(6):536–542. doi:10.1016/j.autrev.2015.02.004.
  • Deese J, Masson L, Miller W, et al. Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract. Am J Reprod Immunol. 2015;74(4):357–367. doi:10.1111/aji.12415.
  • Hughes GC. Progesterone and autoimmune disease. Autoimmun Rev. 2012;11(6-7):A502–514. doi:10.1016/j.autrev.2011.12.003.
  • Polikarpova AV, Levina IS, Sigai NV, et al. Immunomodulatory effects of progesterone and selective ligands of membrane progesterone receptors. Steroids. 2019;145:5–18. doi:10.1016/j.steroids.2019.02.009.
  • Piccinni MP, et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol. Baltim. Md. 1950; 155:128–133. 1995).
  • Foo YZ, Nakagawa S, Rhodes G, Simmons LW. The effects of sex hormones on immune function: a meta-analysis. Biol Rev Camb Philos Soc. 2017;92(1):551–571. doi:10.1111/brv.12243.
  • Guevara Patiño JA, Marino MW, Ivanov VN, Nikolich-Zugich J. Sex steroids induce apoptosis of CD8 + CD4+ double-positive thymocytes via TNF-alpha. Eur J Immunol. 2000;30(9):2586–2592. doi:10.1002/1521-4141(200009)30:9<2586::AID-IMMU2586>3.0.CO;2-L.
  • Zhu M-L, Bakhru P, Conley B, et al. Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator. Nat Commun. 2016;7:11350. doi:10.1038/ncomms11350.
  • Velardi E, Tsai JJ, Holland AM, et al. Sex steroid blockade enhances thymopoiesis by modulating Notch signaling. J Exp Med. 2014;211(12):2341–2349. doi:10.1084/jem.20131289.
  • Doshi A, Chataway J. Multiple sclerosis, a treatable disease. Clin Med (Lond)). 2016;16(Suppl 6):s53–s59. doi:10.7861/clinmedicine.16-6-s53.
  • Owens GM. Economic burden of multiple sclerosis and the role of managed sare organizations in multiple sclerosis management. Am J Manag Care. 2016;22(6 Suppl):S151–S158.
  • Stüve O, Marra CM, Jerome KR, et al. Immune surveillance in multiple sclerosis patients treated with natalizumab. Ann Neurol. 2006;59(5):743–747. doi:10.1002/ana.20858.
  • Rep MHG, Schrijver HM, van Lopik T, et al. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients. J. Neuroimmunol. 1999;96(1):92–100. doi:10.1016/S0165-5728(98)00271-9.
  • Schreiner B, Mitsdoerffer M, Kieseier BC, et al. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J. Neuroimmunol. 2004;155(1-2):172–182. doi:10.1016/j.jneuroim.2004.06.013.
  • Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J Clin Invest. 2000;105(7):967–976. doi:10.1172/JCI8970.
  • Sipe JC, Romine JS, Koziol JA, et al. Development of cladribine treatment in multiple sclerosis. Mult Scler. 1996;1(6):343–347. doi:10.1177/135245859600100612.
  • Stelmasiak Z, Solski J, Nowicki J, et al. Effect of parenteral cladribine on relapse rates in patients with relapsing forms of multiple sclerosis: results of a 2-year, double-blind, placebo-controlled, crossover study. Mult Scler. 2009;15(6):767–770. doi:10.1177/1352458509103610.
  • Karman J, Ling C, Sandor M, Fabry Z. Initiation of Immune Responses in Brain Is Promoted by Local Dendritic Cells. J Immunol. 2004;173(4):2353–2361. doi:10.4049/jimmunol.173.4.2353.
  • Prodinger C, Bunse J, Krüger M, et al. CD11c-expressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol. 2011;121(4):445–458. doi:10.1007/s00401-010-0774-y.
  • Mohammad MG, Tsai VWW, Ruitenberg MJ, et al. Immune cell trafficking from the brain maintains CNS immune tolerance. J Clin Invest. 2014;124(3):1228–1241. doi:10.1172/JCI71544.
  • Zhang Y, Han J, Wu M, et al. Toll-Like Receptor 4 Promotes Th17 Lymphocyte Infiltration Via CCL25/CCR9 in Pathogenesis of Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2019;14(3):493–502. doi:10.1007/s11481-019-09854-1.
  • Larochelle C, Cayrol R, Kebir H, et al. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain. 2012;135(Pt 10):2906–2924. doi:10.1093/brain/aws212.
  • Breuer J, Korpos E, Hannocks M-J, et al. Blockade of MCAM/CD146 impedes CNS infiltration of T cells over the choroid plexus. J Neuroinflammation. 2018;15(1):236. doi:10.1186/s12974-018-1276-4.
  • Lutz SE, Smith JR, Kim DH, et al. Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation. Cell Rep. 2017;21(8):2104–2117. doi:10.1016/j.celrep.2017.10.094.
  • Reboldi A, Coisne C, Baumjohann D, et al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat Immunol. 2009;10(5):514–523. doi:10.1038/ni.1716.
  • Kebir H, Kreymborg K, Ifergan I, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med. 2007;13(10):1173–1175. doi:10.1038/nm1651.
  • Kessenbrock K, Dau T, Jenne DE. Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response. J Mol Med (Berl)). 2011;89(1):23–28. doi:10.1007/s00109-010-0677-3.
  • Balasa R, Bianca C, Septimiu V, et al. The Matrix Metalloproteinases Panel in Multiple Sclerosis Patients Treated with Natalizumab: A Possible Answer to Natalizumab Non- Responders. CNS Neurol Disord Drug Targets. 2018;17(6):464–472. doi:10.2174/1871527317666180703102536.
  • Huppert J, Closhen D, Croxford A, et al. Cellular mechanisms of IL-17-induced blood-brain barrier disruption. Faseb J. 2010;24(4):1023–1034. doi:10.1096/fj.09-141978.
  • Ni C, Wang C, Zhang J, et al. Interferon-γ safeguards blood-brain barrier during experimental autoimmune encephalomyelitis. Am J Pathol. 2014;184(12):3308–3320. doi:10.1016/j.ajpath.2014.08.019.
  • Bartholomäus I, Kawakami N, Odoardi F, et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature. 2009;462(7269):94–98. doi:10.1038/nature08478.
  • Juedes AE, Ruddle NH. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J Immunol. 2001;166(8):5168–5175. doi:10.4049/jimmunol.166.8.5168.
  • Pierson ER, Stromnes IM, Goverman JM. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system. J Immunol. 2014;192(3):929–939. doi:10.4049/jimmunol.1302171.
  • Greter M, Heppner FL, Lemos MP, et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat Med. 2005;11(3):328–334. doi:10.1038/nm1197.
  • Karman J, Chu HH, Co DO, et al. Dendritic cells amplify T cell-mediated immune responses in the central nervous system. J Immunol. 2006;177(11):7750–7760. doi:10.4049/jimmunol.177.11.7750.
  • Bailey SL, Schreiner B, McMahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides ‘preferentially’ polarize CD4+ TH-17 cells in relapsing EAE. Nat Immunol. 2007;8(2):172–180. doi:10.1038/ni1430.
  • Miller SD, McMahon EJ, Schreiner B, Bailey SL. Antigen presentation in the CNS by myeloid dendritic cells drives progression of relapsing experimental autoimmune encephalomyelitis. Ann N Y Acad Sci. 2007;1103:179–191. doi:10.1196/annals.1394.023.
  • Paterka M, Siffrin V, Voss JO, et al. Gatekeeper role of brain antigen-presenting CD11c + cells in neuroinflammation. Embo J. 2016;35(1):89–101. doi:10.15252/embj.201591488.
  • Li Z, He C, Zhang J, et al. P2Y6 deficiency enhances dendritic cell-mediated Th1/Th17 differentiation and aggravates experimental autoimmune encephalomyelitis. JI. 2020;205(2):387–397. doi:10.4049/jimmunol.1900916.
  • Paterka M, Voss JO, Werr J, et al. Dendritic cells tip the balance towards induction of regulatory T cells upon priming in experimental autoimmune encephalomyelitis. J Autoimmun. 2017;76:108–114. doi:10.1016/j.jaut.2016.09.008.
  • Lin C-C, Bradstreet TR, Schwarzkopf EA, et al. IL-1-induced Bhlhe40 identifies pathogenic T helper cells in a model of autoimmune neuroinflammation. J Exp Med. 2016;213(2):251–271. doi:10.1084/jem.20150568.
  • Emming S, Bianchi N, Polletti S, et al. A molecular network regulating the proinflammatory phenotype of human memory T lymphocytes. Nat Immunol. 2020;21(4):388–399. doi:10.1038/s41590-020-0622-8.
  • Lin C-C, et al. Bhlhe40 controls cytokine production by T cells and is essential for pathogenicity in autoimmune neuroinflammation. Nat. Commun. 2014;5:3551.
  • Yu F, Sharma S, Jankovic D, et al. The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination. J Exp Med. 2018;215(7):1813–1821. doi:10.1084/jem.20170155.
  • Lock C, Hermans G, Pedotti R, et al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat Med. 2002;8(5):500–508. doi:10.1038/nm0502-500.
  • Stromnes IM, Goverman JM. Passive induction of experimental allergic encephalomyelitis. Nat Protoc. 2006;1(4):1952–1960. doi:10.1038/nprot.2006.284.
  • O’Connor RA, et al. Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. Baltim. Md 1950. 2008;181:3750–3754.
  • Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet Lond. Engl. 1987;329(8538):893–895. doi:10.1016/S0140-6736(87)92863-7.
  • Carvalheiro T, Rafael-Vidal C, Malvar-Fernandez B, et al. Semaphorin4A-Plexin D1 Axis induces Th2 and Th17 while represses Th1 skewing in an autocrine manner. IJMS. 2020;21(18):6965. doi:10.3390/ijms21186965.
  • Nakatsuji Y, Okuno T, Moriya M, et al. Elevation of Sema4A implicates Th cell skewing and the efficacy of IFN-β Therapy in multiple sclerosis. JI. 2012;188(10):4858–4865. doi:10.4049/jimmunol.1102023.
  • Lublin FD, Knobler RL, Kalman B, et al. Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis. Autoimmunity. 1993;16(4):267–274. doi:10.3109/08916939309014645.
  • Ferber IA, et al. Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol Baltim Md 1950. 1996;156:5–7.
  • Popko B, Baerwald KD. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res. 1999;24(2):331–338. doi:10.1023/A:1022586726510.
  • Prajeeth CK, Löhr K, Floess S, et al. Effector molecules released by Th1 but not Th17 cells drive an M1 response in microglia. Brain Behav Immun. 2014;37:248–259. doi:10.1016/j.bbi.2014.01.001.
  • Miller SD, Vanderlugt CL, Lenschow DJ, et al. Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE. Immunity. 1995;3(6):739–745. doi:10.1016/1074-7613(95)90063-2.
  • Kroenke MA, Carlson TJ, Andjelkovic AV, Segal BM. IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J Exp Med. 2008;205(7):1535–1541. doi:10.1084/jem.20080159.
  • King IL, Dickendesher TL, Segal BM. Circulating Ly-6C + myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood. 2009;113(14):3190–3197. doi:10.1182/blood-2008-07-168575.
  • Ko H-J, Brady JL, Ryg-Cornejo V, et al. GM-CSF-responsive monocyte-derived dendritic cells are pivotal in Th17 pathogenesis. J Immunol. 2014;192(5):2202–2209. doi:10.4049/jimmunol.1302040.
  • Croxford AL, Lanzinger M, Hartmann FJ, et al. The cytokine GM-CSF drives the inflammatory signature of CCR2+ monocytes and licenses autoimmunity. Immunity. 2015;43(3):502–514. doi:10.1016/j.immuni.2015.08.010.
  • Spath S, Komuczki J, Hermann M, et al. Dysregulation of the cytokine GM-CSF induces spontaneous phagocyte invasion and immunopathology in the central nervous system. Immunity. 2017;46(2):245–260. doi:10.1016/j.immuni.2017.01.007.
  • Schinocca C, Rizzo C, Fasano S, et al. Role of the IL-23/IL-17 pathway in rheumatic diseases: an overview. Front Immunol. 2021;12. doi:10.3389/fimmu.2021.637829.
  • Al-Saffar N, Khwaja HA, Kadoya Y, Revell PA. Assessment of the role of GM-CSF in the cellular transformation and the development of erosive lesions around orthopaedic implants. Am J Clin Pathol. 1996;105(5):628–639. doi:10.1093/ajcp/105.5.628.
  • McQualter JL, Darwiche R, Ewing C, et al. Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis. J Exp Med. 2001;194(7):873–882. doi:10.1084/jem.194.7.873.
  • Duhen R, Glatigny S, Arbelaez CA, et al. Cutting edge: the pathogenicity of IFN-γ–producing Th17 cells is independent of T-bet. JI. 2013;190(9):4478–4482. doi:10.4049/jimmunol.1203172.
  • Ganor Y, Teichberg VI, Levite M. TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T Cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavage. J Immunol. 2007;178(2):683–692. doi:10.4049/jimmunol.178.2.683.
  • Poholek CH, et al. Noncanonical STAT3 activity sustains pathogenic Th17 proliferation and cytokine response to antigen. J Exp Med. 2020;217:e20191761.
  • Sen S, He Z, Ghosh S, et al. PRMT1 plays a critical role in Th17 differentiation by regulating reciprocal recruitment of STAT3 and STAT5. J Immunol. 2018;201(2):440–450. doi:10.4049/jimmunol.1701654.
  • Cho JJ, Xu Z, Parthasarathy U, et al. Hectd3 promotes pathogenic Th17 lineage through Stat3 activation and Malt1 signaling in neuroinflammation. Nat Commun. 2019;10(1):701. doi:10.1038/s41467-019-08605-3.
  • Chitrakar A, Budda SA, Henderson JG, Axtell RC, Zenewicz LA. E3 ubiquitin ligase Von Hippel-Lindau protein promotes Th17 differentiation. JI. 2020;205(4):1009–1023. doi:10.4049/jimmunol.2000243.
  • Lee J-Y, Hall JA, Kroehling L, et al. Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell. 2020;180(1):79–91.e16. doi:10.1016/j.cell.2019.11.026.
  • Angiari S, Runtsch MC, Sutton CE, et al. Pharmacological activation of pyruvate kinase M2 inhibits CD4+ T cell pathogenicity and suppresses autoimmunity. Cell Metab. 2020;31(2):391–405.e8. doi:10.1016/j.cmet.2019.10.015.]
  • Damasceno LEA, et al. PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation. J. Exp. Med. 2020;217.
  • Brenner MB, McLean J, Dialynas DP, et al. Identification of a putative second T-cell receptor. Nature. 1986;322(6075):145–149. doi:10.1038/322145a0.
  • Martin B, Hirota K, Cua DJ, Stockinger B, Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity. 2009;31(2):321–330. doi:10.1016/j.immuni.2009.06.020.
  • Lafont V, Liautard J, Liautard JP, Favero J. Production of TNF-alpha by human V gamma 9V delta 2 T cells via engagement of Fc gamma RIIIA, the low affinity type 3 receptor for the Fc portion of IgG, expressed upon TCR activation by nonpeptidic antigen. J Immunol. 2001;166(12):7190–7199. doi:10.4049/jimmunol.166.12.7190.
  • Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006;177(7):4662–4669. doi:10.4049/jimmunol.177.7.4662.
  • Rhodes KA, Andrew EM, Newton DJ, Tramonti D, Carding SR. A subset of IL-10-producing gammadelta T cells protect the liver from Listeria-elicited, CD8(+) T cell-mediated injury. Eur J Immunol. 2008;38(8):2274–2283. doi:10.1002/eji.200838354.
  • Sutton CE, Lalor SJ, Sweeney CM, et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity. 2009;31(2):331–341. doi:10.1016/j.immuni.2009.08.001.
  • Lukens JR, Barr MJ, Chaplin DD, Chi H, Kanneganti T-D. Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4(+) T cells and γδ T cells. J Immunol. 2012;188(7):3107–3115. doi:10.4049/jimmunol.1103308.
  • Zeine R, Pon R, Ladiwala U, et al. Mechanism of gammadelta T cell-induced human oligodendrocyte cytotoxicity: relevance to multiple sclerosis. J. Neuroimmunol. 1998;87(1-2):49–61. doi:10.1016/S0165-5728(98)00047-2.
  • Petermann F, Rothhammer V, Claussen MC, et al. γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity. 2010;33(3):351–363. doi:10.1016/j.immuni.2010.08.013.
  • Kawanokuchi J, Shimizu K, Nitta A, et al. Production and functions of IL-17 in microglia. J Neuroimmunol. 2008;194(1-2):54–61. doi:10.1016/j.jneuroim.2007.11.006.
  • McGinley AM, Sutton CE, Edwards SC, et al. Interleukin-17A serves a priming role in autoimmunity by recruiting IL-1β-producing myeloid cells that promote pathogenic T cells. Immunity. 2020;52(2):342–356.e6. doi:10.1016/j.immuni.2020.01.002.
  • Trajkovic V, Stosic-Grujicic S, Samardzic T, et al. Interleukin-17 stimulates inducible nitric oxide synthase activation in rodent astrocytes. J Neuroimmunol. 2001;119(2):183–191. doi:10.1016/S0165-5728(01)00391-5.
  • Ma X, Reynolds SL, Baker BJ, et al. IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol. 2010;184(9):4898–4906. doi:10.4049/jimmunol.1000142.
  • Shan K, et al. IL-17-triggered downregulation of miR-497 results in high HIF-1α expression and consequent IL-1β and IL-6 production by astrocytes in EAE mice. Cell Mol Immunol. 2017; doi:10.1038/cmi.2017.12.
  • Hauser SL, Bhan AK, Gilles F, et al. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann Neurol. 1986;19(6):578–587. doi:10.1002/ana.410190610.
  • Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med. 2000;192(3):393–404. doi:10.1084/jem.192.3.393.
  • Jilek S, Schluep M, Rossetti AO, et al. CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis. Clin Immunol. 2007;123(1):105–113. doi:10.1016/j.clim.2006.11.004.
  • Ifergan I, Kebir H, Alvarez JI, et al. Central nervous system recruitment of effector memory CD8+ T lymphocytes during neuroinflammation is dependent on α4 integrin. Brain. 2011;134(Pt 12):3560–3577. doi:10.1093/brain/awr268.
  • Malmeström C, Lycke J, Haghighi S, et al. Relapses in multiple sclerosis are associated with increased CD8+ T-cell mediated cytotoxicity in CSF. J Neuroimmunol. 2008;196(1-2):159–165. doi:10.1016/j.jneuroim.2008.03.001.
  • Polman CH, O’Connor PW, Havrdova E, et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006;354(9):899–910. doi:10.1056/NEJMoa044397.
  • Ransohoff RM, Estes ML. Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy. Arch Neurol. 1991;48(12):1244–1246. doi:10.1001/archneur.1991.00530240048017.
  • Gobin SJP, Montagne L, Van Zutphen M, et al. Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions. Glia. 2001;36(1):68–77. doi:10.1002/glia.1096.
  • Höftberger R, Aboul-Enein F, Brueck W, et al. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 2004;14(1):43–50. doi:10.1111/j.1750-3639.2004.tb00496.x.
  • Sauer BM, Schmalstieg WF, Howe CL. Axons are injured by antigen-specific CD8(+) T cells through a MHC class I- and granzyme B-dependent mechanism. Neurobiol Dis. 2013;59:194–205. doi:10.1016/j.nbd.2013.07.010.
  • Pouly S, Becher B, Blain M, Antel JP. Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol. 2000;59(4):280–286. doi:10.1093/jnen/59.4.280.
  • Medana I, Li Z, Flügel A, et al. Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity. J Immunol. 2001;167(2):674–681. doi:10.4049/jimmunol.167.2.674.
  • Sasaki K, Bean A, Shah S, et al. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. J Immunol. 2014;192(7):3029–3042. doi:10.4049/jimmunol.1302911.
  • Machado-Santos J, Saji E, Tröscher AR, et al. The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+ T lymphocytes and B cells. Brain. 2018;141(7):2066–2082. doi:10.1093/brain/awy151.
  • Saligrama N, Zhao F, Sikora MJ, et al. Opposing T cell responses in experimental autoimmune encephalomyelitis. Nature. 2019;572(7770):481–487. doi:10.1038/s41586-019-1467-x.
  • Peng Y, Zhu F-Z, Chen Z-X, et al. Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis. Chin Med J (Engl). 2019;132(24):2934–2940. doi:10.1097/CM9.0000000000000551.
  • Wagner CA, Roqué PJ, Mileur TR, Liggitt D, Goverman JM. Myelin-specific CD8+ T cells exacerbate brain inflammation in CNS autoimmunity. J. Clin. Invest. 2019;130(1):203–213. doi:10.1172/JCI132531.
  • Fritzsching B, Haas J, König F, et al. Intracerebral human regulatory T Cells: analysis of CD4+ CD25+ FOXP3+ T cells in brain lesions and cerebrospinal fluid of multiple sclerosis patients. PLoS ONE. 2011;6(3):e17988. doi:10.1371/journal.pone.0017988.
  • Othy S, Jairaman A, Dynes JL, et al. Regulatory T cells suppress Th17 cell Ca2+ signaling in the spinal cord during murine autoimmune neuroinflammation. Proc Natl Acad Sci USA. 2020;117(33):20088–20099. doi:10.1073/pnas.2006895117.
  • Putheti P, Soderstrom M, Link H, Huang Y-M. Effect of glatiramer acetate (Copaxone) on CD4 + CD25high T regulatory cells and their IL-10 production in multiple sclerosis. J. Neuroimmunol. 2003;144(1-2):125–131. doi:10.1016/j.jneuroim.2003.08.001.
  • Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4 + CD25+ regulatory T cells in patients with multiple sclerosis. J Exp Med. 2004;199(7):971–979. doi:10.1084/jem.20031579.
  • Kumar M, Putzki N, Limmroth V, et al. CD4 + CD25 + FoxP3+ T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis. J. Neuroimmunol. 2006;180(1-2):178–184. doi:10.1016/j.jneuroim.2006.08.003.
  • Venken K, Hellings N, Broekmans T, et al. Natural naive CD4 + CD25 + CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J Immunol. 2008;180(9):6411–6420. 1950 doi:10.4049/jimmunol.180.9.6411.
  • Balint B, Haas J, Schwarz A, et al. T-cell homeostasis in pediatric multiple sclerosis: Old cells in young patients. Neurology. 2013;81(9):784–792. doi:10.1212/WNL.0b013e3182a2ce0e.
  • Filippi M, et al. Multiple sclerosis. Nat Rev Dis Primer. 2018;4:43.
  • Nicot A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci (Landmark Ed)). 2009;14:4477–4515. doi:10.2741/3543.
  • Bove R, Chitnis T. Sexual disparities in the incidence and course of MS. Clin Immunol Orlando Fla. 2013;149(2):201–210. doi:10.1016/j.clim.2013.03.005.
  • Desai MK, Brinton RD. Autoimmune disease in women: endocrine transition and risk across the lifespan. Front Endocrinol (Lausanne). 2019;10:265. doi:10.3389/fendo.2019.00265.
  • Wiedrick J, Meza-Romero R, Gerstner G, et al. Sex differences in EAE reveal common and distinct cellular and molecular components. Cell Immunol. 2021;359:104242. doi:10.1016/j.cellimm.2020.104242.
  • Haghmorad D, Amini AA, Mahmoudi MB, et al. Pregnancy level of estrogen attenuates experimental autoimmune encephalomyelitis in both ovariectomized and pregnant C57BL/6 mice through expansion of Treg and Th2 cells. J Neuroimmunol. 2014;277(1-2):85–95. doi:10.1016/j.jneuroim.2014.10.004.
  • Spanier JA, Nashold FE, Mayne CG, Nelson CD, Hayes CE. Vitamin D and estrogen synergy in Vdr-expressing CD4(+) T cells is essential to induce Helios(+)FoxP3(+) T cells and prevent autoimmune demyelinating disease. J Neuroimmunol. 2015;286:48–58. doi:10.1016/j.jneuroim.2015.06.015.
  • Russi AE, Ebel ME, Yang Y, Brown MA. Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility. Proc Natl Acad Sci USA. 2018;115(7):E1520–E1529. doi:10.1073/pnas.1710401115.
  • Xiao Y, Lai L, Chen H, et al. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells. Mol Immunol. 2018;101:550–563. doi:10.1016/j.molimm.2018.08.026.
  • Finlay CM, Cunningham KT, Doyle B, Mills KHG. IL-33-stimulated murine mast cells polarize alternatively activated macrophages, which suppress T cells that mediate experimental autoimmune encephalomyelitis. J Immunol. 2020;205(7):1909–1919. doi:10.4049/jimmunol.1901321.
  • Dhaeze T, Lachance C, Tremblay L, et al. Sex-dependent factors encoded in the immune compartment dictate relapsing or progressive phenotype in demyelinating disease. JCI Insight. 2019;4(6). doi:10.1172/jci.insight.124885.
  • Bouhassira D. Neuropathic pain: definition, assessment and epidemiology. Rev Neurol (Paris)). 2019;175(1-2):16–25. doi:10.1016/j.neurol.2018.09.016.
  • Sorge RE, Mapplebeck JCS, Rosen S, et al. Different immune cells mediate mechanical pain hypersensitivity in male and female mice. Nat Neurosci. 2015;18(8):1081–1083. doi:10.1038/nn.4053.
  • Chernov AV, Hullugundi SK, Eddinger KA, et al. A myelin basic protein fragment induces sexually dimorphic transcriptome signatures of neuropathic pain in mice. J Biol Chem. 2020;295(31):10807–10821. doi:10.1074/jbc.RA120.013696.
  • Kobayashi Y, Kiguchi N, Fukazawa Y, et al. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system. J Biol Chem. 2015;290(20):12603–12613. doi:10.1074/jbc.M115.636506.
  • Cao L, DeLeo JA. CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain. Eur J Immunol. 2008;38(2):448–458. doi:10.1002/eji.200737485.
  • Costigan M, Moss A, Latremoliere A, et al. T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity. J Neurosci. 2009;29(46):14415–14422. doi:10.1523/JNEUROSCI.4569-09.2009.
  • Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience. 2004;129(3):767–777. doi:10.1016/j.neuroscience.2004.08.035.
  • Cobos EJ, Nickerson CA, Gao F, et al. Mechanistic differences in neuropathic pain modalities revealed by correlating behavior with global expression profiling. Cell Rep. 2018;22(5):1301–1312. doi:10.1016/j.celrep.2018.01.006.
  • Kleinschnitz C, Hofstetter HH, Meuth SG, et al. T cell infiltration after chronic constriction injury of mouse sciatic nerve is associated with interleukin-17 expression. Exp Neurol. 2006;200(2):480–485. doi:10.1016/j.expneurol.2006.03.014.
  • Kim CF, Moalem-Taylor G. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain. 2011;12(3):370–383. doi:10.1016/j.jpain.2010.08.003.
  • Schmid AB, Coppieters MW, Ruitenberg MJ, McLachlan EM. Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats. J Neuropathol Exp Neurol. 2013;72(7):662–680. doi:10.1097/NEN.0b013e318298de5b.
  • Davoli-Ferreira M, de Lima KA, Fonseca MM, et al. Regulatory T cells counteract neuropathic pain through inhibition of the Th1 response at the site of peripheral nerve injury. PainPublish Ahead of Print. 2020;161(8):1730–1743. doi:10.1097/j.pain.0000000000001879.
  • Noor S, et al. LFA-1 antagonist (BIRT377) similarly reverses peripheral neuropathic pain in male and female mice with underlying sex divergent peripheral immune proinflammatory phenotypes. Neuroimmunol Neuroinflammation. 2019;6.
  • Day Y-J, Liou J-T, Lee C-M, et al. Lack of interleukin-17 leads to a modulated micro-environment and amelioration of mechanical hypersensitivity after peripheral nerve injury in mice. Pain. 2014;155(7):1293–1302. doi:10.1016/j.pain.2014.04.004.
  • Hartlehnert M, Derksen A, Hagenacker T, et al. Schwann cells promote post-traumatic nerve inflammation and neuropathic pain through MHC class II. Sci Rep. 2017;7(1):12518. doi:10.1038/s41598-017-12744-2.
  • Hu P, Bembrick AL, Keay KA, McLachlan EM. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. Brain Behav Immun. 2007;21(5):599–616. doi:10.1016/j.bbi.2006.10.013.
  • Hu P, McLachlan EM. Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat. Neuroscience. 2002;112(1):23–38. doi:10.1016/S0306-4522(02)00065-9.
  • Du B, Ding Y-Q, Xiao X, et al. CD4+ αβ T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries. J Neuroinflammation. 2018;15(1):81. doi:10.1186/s12974-018-1115-7.
  • Donnelly CR, Andriessen AS, Chen G, et al. Central nervous system targets: glial cell mechanisms in chronic pain. Neurotherapeutics. 2020;17(3):846–860. doi:10.1007/s13311-020-00905-7.
  • Sun C, Zhang J, Chen L, et al. IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines. Mol Med Rep. 2017;15(1):89–96. doi:10.3892/mmr.2016.6018.
  • Tsuda M, Masuda T, Kitano J, et al. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci USA. 2009;106(19):8032–8037. doi:10.1073/pnas.0810420106.
  • Draleau K, et al. Phenotypic identification of spinal cord-infiltrating CD4+ T lymphocytes in a murine model of neuropathic pain. J. Pain Relief. 2014;Suppl 3(003).
  • Kavelaars A, C. J H. T-cells as guardians of pain resolution. Trends Mol Med. 2021;
  • Labuz D, Schreiter A, Schmidt Y, Brack A, Machelska H. T lymphocytes containing β-endorphin ameliorate mechanical hypersensitivity following nerve injury. Brain Behav Immun. 2010;24(7):1045–1053. doi:10.1016/j.bbi.2010.04.001.
  • Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018;175(14):2717–2725. doi:10.1111/bph.13750.
  • Lees JG, Duffy SS, Perera CJ, Moalem-Taylor G. Depletion of Foxp3+ regulatory T cells increases severity of mechanical allodynia and significantly alters systemic cytokine levels following peripheral nerve injury. Cytokine. 2015;71(2):207–214. doi:10.1016/j.cyto.2014.10.028.
  • Fischer R, Sendetski M, Del Rivero T, et al. TNFR2 promotes Treg-mediated recovery from neuropathic pain across sexes. Proc Natl Acad Sci USA. 2019;116(34):17045–17050. doi:10.1073/pnas.1902091116.
  • Kwilasz AJ, Grace PM, Serbedzija P, Maier SF, Watkins LR. The therapeutic potential of interleukin-10 in neuroimmune diseases. Neuropharmacology. 2015;96(Pt A):55–69. doi:10.1016/j.neuropharm.2014.10.020.
  • Amariuta T, Luo Y, Knevel R, Okada Y, Raychaudhuri S. Advances in genetics toward identifying pathogenic cell states of rheumatoid arthritis. Immunol Rev. 2020;294(1):188–204. doi:10.1111/imr.12827.
  • Vyas SP, Hansda AK, Goswami R. Rheumatoid arthritis: ‘melting pot’ of T helper subsets. Int Rev Immunol. 2019;38(5):212–231. doi:10.1080/08830185.2019.1621865.
  • Bauer ME. Accelerated immunosenescence in rheumatoid arthritis: impact on clinical progression. Immun Ageing. 2020;17:6. doi:10.1186/s12979-020-00178-w.
  • van Vollenhoven RF. Sex differences in rheumatoid arthritis: more than meets the eye. BMC Med. 2009;7:12. doi:10.1186/1741-7015-7-12.
  • Albrecht K. [Gender-specific differences in comorbidities of rheumatoid arthritis]. Z Rheumatol. 2014;73(7):607–614. doi:10.1007/s00393-014-1410-3.
  • Goemaere S, Ackerman C, Goethals K, et al. Onset of symptoms of rheumatoid arthritis in relation to age, sex and menopausal transition. J Rheumatol. 1990;17(12):1620–1622.
  • Maynard C, Mikuls TR, Cannon GW, et al. Sex differences in the achievement of remission and low disease activity in rheumatoid arthritis. Arthritis Care Res. 2020;72(3):326–333. doi:10.1002/acr.23873.
  • Wallenius M, Skomsvoll JF, Koldingsnes W, et al. Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scand. J. Rheumatol. 2009;38(3):178–183. doi:10.1080/03009740802400594.
  • Favalli EG, Biggioggero M, Crotti C, et al. Sex and management of rheumatoid arthritis. Clin Rev Allergy Immunol. 2019;56(3):333–345. doi:10.1007/s12016-018-8672-5.
  • Weyand CM, Goronzy JJ. The immunology of rheumatoid arthritis. Nat Immunol. 2021;22(1):10–18. doi:10.1038/s41590-020-00816-x.
  • van der Woude D, van der Helm-van Mil AHM. Update on the epidemiology, risk factors, and disease outcomes of rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2018;32(2):174–187. doi:10.1016/j.berh.2018.10.005.
  • Gameiro J, Nagib P, Verinaud L. The thymus microenvironment in regulating thymocyte differentiation. Cell Adhes. Migr. 2010;4(3):382–390. doi:10.4161/cam.4.3.11789.
  • Giannini D, Antonucci M, Petrelli F, et al. One year in review 2020: pathogenesis of rheumatoid arthritis. Clin Exp Rheumatol. 2020;38(3):387–397.
  • Wehr P, Purvis H, Law S-C, Thomas R. Dendritic cells, T cells and their interaction in rheumatoid arthritis. Clin Exp Immunol. 2019;196(1):12–27. doi:10.1111/cei.13256.
  • Auréal M, Machuca-Gayet I, Coury F. Rheumatoid Arthritis in the View of Osteoimmunology. Biomolecules. 2020;11(1):48. doi:10.3390/biom11010048.
  • van Onna M, Boonen A. The challenging interplay between rheumatoid arthritis, ageing and comorbidities. BMC Musculoskelet Disord. 2016;17:184. doi:10.1186/s12891-016-1038-3.
  • Taylor PC, et al. The key comorbidities in patients with rheumatoid arthritis: a narrative review. J Clin Med. 2021;10.
  • Basile MS, et al. Cognitive decline in rheumatoid arthritis: insight into the molecular pathogenetic mechanisms. Int J Mol Sci. 2021;22.
  • Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233–255. doi:10.1111/j.0105-2896.2009.00859.x.
  • Cai W-W, Yu Y, Zong S-Y, Wei F. Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis. Inflamm Res. 2020;69(11):1087–1101. doi:10.1007/s00011-020-01391-5.
  • Li Y, Goronzy JJ, Weyand CM. DNA damage, metabolism and aging in pro-inflammatory T cells: rheumatoid arthritis as a model system. Exp Gerontol. 2018;105:118–127. doi:10.1016/j.exger.2017.10.027.
  • Hu X, Wu Y-J, Zhang J, Wei W. T-cells interact with B cells, dendritic cells, and fibroblast-like synoviocytes as hub-like key cells in rheumatoid arthritis. Int Immunopharmacol. 2019;70:428–434. doi:10.1016/j.intimp.2019.03.008.
  • Schneider A, Rieck M, Sanda S, et al. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J Immunol. 2008;181(10):7350–7355. doi:10.4049/jimmunol.181.10.7350.
  • Weyand CM, Wu B, Goronzy JJ. The metabolic signature of T cells in rheumatoid arthritis. Curr Opin Rheumatol. 2020;32(2):159–167. doi:10.1097/BOR.0000000000000683.
  • Chemin K, Gerstner C, Malmström V. Effector functions of CD4+ T cells at the site of local autoimmune inflammation-lessons from rheumatoid arthritis. Front Immunol. 2019;10:353. doi:10.3389/fimmu.2019.00353.
  • Kamali AN, Noorbakhsh SM, Hamedifar H, et al. A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders. Mol Immunol. 2019;105:107–115. doi:10.1016/j.molimm.2018.11.015.
  • Bank I. The role of gamma delta T cells in autoimmune rheumatic diseases. Cells. 2020;9(2):462. doi:10.3390/cells9020462.
  • Jung JH, et al. Synovial fluid CD69 + CD8+ T cells with tissue-resident phenotype mediate perforin-dependent citrullination in rheumatoid arthritis. Clin Transl Immunol. 2020;9:e1140.
  • Li Y, Luo W, Zhu S, Lei G. T cells in osteoarthritis: alterations and beyond. Front Immunol. 2017;8 doi:10.3389/fimmu.2017.00356.
  • Woodell-May JE, Sommerfeld SD. Role of Inflammation and the immune system in the progression of osteoarthritis. J Orthop Res. 2020;38(2):253–257. doi:10.1002/jor.24457.
  • Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323–1330. doi:10.1136/annrheumdis-2013-204763.
  • Haseeb A, Haqqi TM. Immunopathogenesis of osteoarthritis. Clin Immunol. 2013;146(3):185–196. doi:10.1016/j.clim.2012.12.011.
  • Kulkarni P, Martson A, Vidya R, Chitnavis S, Harsulkar A. Chapter Two - Pathophysiological landscape of osteoarthritis. In Makowski GS, Advances in Clinical Chemistry, Elsevier, 2021;100:37–90.
  • Kalaitzoglou E, Griffin TM, Humphrey MB. Innate immune responses and osteoarthritis. Curr Rheumatol Rep. 2017;19:45.
  • Livshits G, Kalinkovich A. Hierarchical, imbalanced pro-inflammatory cytokine networks govern the pathogenesis of chronic arthropathies. Osteoarthritis Cartilage. 2018;26(1):7–17. doi:10.1016/j.joca.2017.10.013.
  • Silawal S, Triebel J, Bertsch T, Schulze-Tanzil G. Osteoarthritis and the complement cascade. Clin Med Insights Arthritis Musculoskelet Disord. 2018;11:11795441177514301179544117751430 doi:10.1177/1179544117751430.
  • Chow YY, Chin K-Y. The role of inflammation in the pathogenesis of osteoarthritis. Mediators Inflamm. 2020;2020:1–19. doi:10.1155/2020/8293921.
  • Mehana E-SE, Khafaga AF, El-Blehi SS. The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review. Life Sci. 2019;234:116786. doi:10.1016/j.lfs.2019.116786.
  • Lopes EBP, Filiberti A, Husain SA, Humphrey MB. Immune contributions to osteoarthritis. Curr Osteoporos Rep. 2017;15(6):593–600. doi:10.1007/s11914-017-0411-y.
  • Ishii H, Tanaka H, Katoh K, et al. Characterization of infiltrating T cells and Th1/Th2-type cytokines in the synovium of patients with osteoarthritis. Osteoarthritis Cartilage. 2002;10(4):277–281. doi:10.1053/joca.2001.0509.
  • Zhu W, Zhang X, Jiang Y, et al. Alterations in peripheral T cell and B cell subsets in patients with osteoarthritis. Clin Rheumatol. 2020;39(2):523–532. doi:10.1007/s10067-019-04768-y.
  • Nees TA, et al. T helper cell infiltration in osteoarthritis-related knee pain and disability. J Clin Med. 2020;9.
  • Rosshirt N, Hagmann S, Tripel E, et al. A predominant Th1 polarization is present in synovial fluid of end-stage osteoarthritic knee joints: analysis of peripheral blood, synovial fluid and synovial membrane. Clin Exp Immunol. 2019;195(3):395–406. doi:10.1111/cei.13230.
  • Sakkas LI, Platsoucas CD. The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum. 2007;56(2):409–424. doi:10.1002/art.22369.
  • Sakata M, et al. Osteoarthritic articular chondrocytes stimulate autologous T cell responses in vitro. Clin Exp Rheumatol. 2003;21:704–710.
  • Platzer H, et al. Impact of mononuclear cell infiltration on chondrodestructive MMP/ADAMTS production in osteoarthritic knee joints-an ex vivo study. J Clin Med. 2020;9.
  • Sussman M, Benner J, Haller MJ, Rewers M, Griffiths R. Estimated lifetime economic burden of type 1 diabetes. Diabetes Technol Ther. 2020;22(2):121–130. doi:10.1089/dia.2019.0398.
  • Chiang JL, Kirkman MS, Laffel LMB, Peters AL. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37(7):2034–2054. doi:10.2337/dc14-1140.
  • Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nat Rev Endocrinol. 2019;15(11):635–650. doi:10.1038/s41574-019-0254-y.
  • Singh B, Delovitch TL. Immune mechanisms that regulate susceptibility to autoimmune type I diabetes. CRIAI. 2000;19(3):247–264. doi:10.1385/CRIAI:19:3:247.
  • Han S, Donelan W, Wang H, Reeves W, Yang L-J. Novel autoantigens in type 1 diabetes. Am J Transl Res. 2013;5(4):379–392.
  • Jacobson DL, Gange SJ, Rose NR, Graham NM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol. 1997;84(3):223–243. doi:10.1006/clin.1997.4412.
  • Frommer L, Kahaly GJ. Type 1 diabetes and associated autoimmune diseases. World J Diabetes. 2020;11(11):527–539. doi:10.4239/wjd.v11.i11.527.
  • Young EF, Hess PR, Arnold LW, Tisch R, Frelinger JA. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. Autoimmunity. 2009;42(8):678–691. doi:10.3109/08916930903213993.
  • Campbell-Thompson M, Fu A, Kaddis JS, et al. Insulitis and β-cell mass in the natural history of type 1 diabetes. Diabetes. 2016;65(3):719–731. doi:10.2337/db15-0779.
  • Campbell-Thompson ML, Atkinson MA, Butler AE, et al. The diagnosis of insulitis in human type 1 diabetes. Diabetologia. 2013;56(11):2541–2543. doi:10.1007/s00125-013-3043-5.
  • Kay TW, Parker JL, Stephens LA, Thomas HE, Allison J. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol. 1996;157(8):3688–3693.
  • Foulis AK, Farquharson MA, Hardman R. Aberrant expression of class II major histocompatibility complex molecules by B cells and hyperexpression of Class I major histocompatibility complex molecules by insulin containing islets in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987;30(5):333–343. doi:10.1007/BF00299027.
  • Foulis AK, McGill M, Farquharson MA. Insulitis in type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-gamma containing cells. J Pathol. 1991;165(2):97–103. doi:10.1002/path.1711650203.
  • Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009;155(2):173–181. doi:10.1111/j.1365-2249.2008.03860.x.
  • Hamilton-Williams EE, Palmer SE, Charlton B, Slattery RM. Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci USA. 2003;100(11):6688–6693. doi:10.1073/pnas.1131954100.
  • Falcone M, Fousteri G. Role of the PD-1/PD-L1 dyad in the maintenance of pancreatic immune tolerance for prevention of type 1 diabetes. Front Endocrinol. 2020;11 doi:10.3389/fendo.2020.00569.
  • Höglund P, Mintern J, Waltzinger C, et al. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med. 1999;189(2):331–339. doi:10.1084/jem.189.2.331.
  • Hultgren B, Huang X, Dybdal N, Stewart TA. Genetic absence of -interferon delays but does not prevent diabetes in NOD mice. Diabetes. 1996;45(6):812–817. doi:10.2337/diabetes.45.6.812.
  • Kägi D, Odermatt B, Seiler P, et al. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J Exp Med. 1997;186(7):989–997. doi:10.1084/jem.186.7.989.
  • Savinov AY, Tcherepanov A, Green EA, Flavell RA, Chervonsky AV. Contribution of Fas to diabetes development. Proc Natl Acad Sci U S A. 2003;100(2):628–632. doi:10.1073/pnas.0237359100.
  • Wiedeman AE, Muir VS, Rosasco MG, et al. Autoreactive CD8+ T cell exhaustion distinguishes subjects with slow type 1 diabetes progression. J Clin Invest. 2020;130(1):480–490. doi:10.1172/JCI126595.
  • Arif S, Moore F, Marks K, et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes. 2011;60(8):2112–2119. doi:10.2337/db10-1643.
  • Kuriya G, Uchida T, Akazawa S, et al. Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse. Diabetologia. 2013;56(8):1773–1780. doi:10.1007/s00125-013-2935-8.
  • Campbell IL, Kay TW, Oxbrow L, Harrison LC. Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest. 1991;87(2):739–742. doi:10.1172/JCI115055.
  • Debray-Sachs M, Carnaud C, Boitard C, et al. Prevention of diabetes in NOD mice treated with antibody to murine IFNγ. J. Autoimmun. 1991;4(2):237–248. doi:10.1016/0896-8411(91)90021-4.
  • von Herrath MG, Oldstone MB. Interferon-gamma is essential for destruction of beta cells and development of insulin-dependent diabetes mellitus. J Exp Med. 1997;185(3):531–539. doi:10.1084/jem.185.3.531.
  • Sobel DO, Han J, Williams J, et al. Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse. J Autoimmun. 2002;19(3):129–137. doi:10.1006/jaut.2002.0604.
  • Shapiro MR, Yeh W-I, Longfield JR, et al. CD226 deletion reduces type 1 diabetes in the NOD mouse by impairing thymocyte development and peripheral T cell activation. Front Immunol. 2020;11:2180. doi:10.3389/fimmu.2020.02180.
  • Eichmann M, Baptista R, Ellis RJ, et al. Costimulation blockade disrupts CD4+ T Cell memory pathways and uncouples their link to decline in β-Cell function in type 1 diabetes. J Immunol. 2020;204(12):3129–3138. doi:10.4049/jimmunol.1901439.
  • Terrazzano G, Bruzzaniti S, Rubino V, et al. T1D progression is associated with loss of CD3 + CD56+ regulatory T cells that control CD8+ T cell effector functions. Nat Metab. 2020;2(2):142–152. doi:10.1038/s42255-020-0173-1.
  • Brusko TM, Wasserfall CH, Clare-Salzler MJ, Schatz DA, Atkinson MA. Functional Defects and the Influence of Age on the Frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes. 2005;54(5):1407–1414. doi:10.2337/diabetes.54.5.1407.
  • Lindley S, Dayan CM, Bishop A, et al. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes. 2005;54(1):92–99. doi:10.2337/diabetes.54.1.92.
  • Wen X, Yang J, James E, et al. Increased islet antigen-specific regulatory and effector CD4+ T cells in healthy individuals with the type 1 diabetes-protective haplotype. Sci Immunol. 2020;5(44):eaax8767. doi:10.1126/sciimmunol.aax8767.
  • Ryba M, Hak L, Zorena K, Myśliwiec M, Myśliwska J. [Regulatory T lymphocytes expressing L-selectin in children and adolescents with type 1 diabetes mellitus. Pediatr Endocrinol Diabetes Metab. 2010;16(1):12–16.
  • Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001;27(1):18–20. doi:10.1038/83707.
  • Serr I, Scherm MG, Zahm AM, et al. A miRNA181a/NFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabetes. Sci Transl Med. 2018;10(422):eaag1782. doi:10.1126/scitranslmed.aag1782.
  • Zhang J, Chen L, Wang F, et al. Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability. Diabetologia. 2020;63(5):987–1001. doi:10.1007/s00125-020-05105-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.